nirogacestat
springworks therapeutics
['nirogacestat']
 nirogacestat demonstrated rapid, sustained, and statistically significant improvements in all primary and secondary efficacy end points, lead study author bernd kasper, md, phd, a professor at the universit tsmedizin mannheim in germany, said. #esmo2022 
Oncology news and insights from leading researchers and cancer centers.